CSOP HEALTHCARE

3174
3.4382.11% ( -0.074 )
Delay Closed: Nov 16, 16:08:00

Wiki

About

The investment objective of the CSOP China Healthcare Disruption Index ETF (the Sub-Fund) is to provide investment results that, before deduction of fees and expenses, closely correspond to the performance of the Index, namely, Solactive China Healthcare Disruption Index (the Index).

Name
CSOP HEALTHCARE
Index tracked
Hang Seng Biotech TR HKD
Type
Equity
Expense ratio
0.99%
Management fee
0.99%
Dividend policy
Annually
NAV
HKD 3.5137 (11/12/2026)
Issued units
256.86M (11/13/2026)
Listing date
Jul 21, 2021
Sponsor
CSOP Asset Management Limited
Custodian
--

ETF Documents

Last updatedType
10/09/2026Factsheet
05/08/2026Annual Report
10/09/2026Prospectus